Martin Shkreli, also known as “Pharma Bro,” recently shared his bearish views on Bitcoin, MicroStrategy, and several quantum computing stocks. Despite his controversial past, Shkreli’s track record suggests he has a knack for identifying market trends. He argues that these assets are overvalued due to market complacency and could experience significant corrections.
However, his contrarian approach carries risks, and investors should exercise caution when making decisions based on his predictions.
Source
